The DOI matches its Crossref record; 110 of the 110 references it cites were found in a registry or an index.
MYBL2 (B-Myb): a central regulator of cell proliferation, cell survival and differentiation involved in tumorigenesis
Open accessAbstract
Limitless cell proliferation, evasion from apoptosis, dedifferentiation, metastatic spread and therapy resistance: all these properties of a cancer cell contribute to its malignant phenotype and affect patient outcome. MYBL2 (alias B-Myb) is a transcription factor of the MYB transcription factor family and a physiological regulator of cell cycle progression, cell survival and cell differentiation. When deregulated in cancer cells, MYBL2 mediates the deregulation of these properties. In fact, MYBL2 is overexpressed and associated with poor patient outcome in numerous cancer entities. MYBL2 and players of its downstream transcriptional network can be used as prognostic and/or predictive biomarkers as well as potential therapeutic targets to offer less toxic and more specific anti-cancer therapies in future. In this review, we summarize current knowledge on the physiological roles of MYBL2 and highlight the impact of its deregulation on cancer initiation and progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Cellular senescence: when bad things happen to good cells
Campisi, J., & d'Adda di Fagagna, F. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2233 · Cited by 4,441
The history and future of targeting cyclin-dependent kinases in cancer therapy
Asghar, U., Witkiewicz, A. K., Turner, N. C., & Knudsen, E. S. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4504 · Cited by 1,767
A functional c-myb gene is required for normal murine fetal hepatic hematopoiesis
Mucenski, M. L., McLain, K., Kier, A. B., Swerdlow, S. H., Schreiner, C. M., Miller, T. A., Pietryga, D. W., Scott, W. J., & Potter, S. S. (1991) · Cell · doi:10.1016/0092-8674(91)90099-k · Cited by 1,042
MYB function in normal and cancer cells
Ramsay, R. G., & Gonda, T. J. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2439 · Cited by 617
The DREAM complex: master coordinator of cell cycle-dependent gene expression
Sadasivam, S., & DeCaprio, J. A. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3556 · Cited by 524
Epithelial–mesenchymal transition (EMT) and metastasis: yes, no, maybe?
Diepenbruck, M., & Christofori, G. (2016) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2016.06.002 · Cited by 475
Survivin: a unique target for tumor therapy
Garg, H., Suri, P., Gupta, J. C., Talwar, G. P., & Dubey, S. (2016) · Cancer Cell International · doi:10.1186/s12935-016-0326-1 · Cited by 437
Three new types of viral oncogene of cellular origin specific for haematopoietic cell transformation
Roussel, M., Saule, S., Lagrou, C., Rommens, C., Beug, H., Graf, T., & Stehelin, D. (1979) · Nature · doi:10.1038/281452a0 · Cited by 423
Aurora Kinases as Anticancer Drug Targets
Gautschi, O., Heighway, J., Mack, P. C., Purnell, P. R., Lara, P. N., & Gandara, D. R. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-2179 · Cited by 386
Frequent amplification of chromosomal region 20q12-q13 in ovarian cancer.
Tanner, M., Grénman, S., Koul, A., Johannsson, O. T., Meltzer, P. S., Pejovic, T. B., Borg, Å., & Isola, J. J. (2000) · PubMed · Cited by 370
Fu, Z., Malureanu, L., Huang, J., Wang, W., Li, H., van Deursen, J. M., Tindall, D. J., & Chen, J. (2008) · Nature Cell Biology · doi:10.1038/ncb1767 · Cited by 355
The p53-p21-DREAM-CDE/CHR pathway regulates G2/M cell cycle genes
Fischer, M., Quaas, M., Steiner, L., & Engeland, K. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv927 · Cited by 321
E2Fs link the control of G1/S and G2/M transcription
Zhu, W., Giangrande, P. H., & Nevins, J. R. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600459 · Cited by 320
The MuvB complex sequentially recruits B-Myb and FoxM1 to promote mitotic gene expression
Sadasivam, S., Duan, S., & DeCaprio, J. A. (2012) · Genes & Development · doi:10.1101/gad.181933.111 · Cited by 309
Mechanisms of microRNA deregulation in human cancer
Deng, S., Calin, G. A., Croce, C. M., Coukos, G., & Zhang, L. (2008) · Cell Cycle · doi:10.4161/cc.7.17.6597 · Cited by 305
Chae, Y. K., Ranganath, K., Hammerman, P. S., Vaklavas, C., Mohindra, N., Kalyan, A., Matsangou, M., Costa, R., Carneiro, B., Villaflor, V. M., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.14109 · Cited by 298
Vrana, J. A., Decker, R. H., Johnson, C. R., Wang, Z., Jarvis, W. D., Richon, V. M., Ehinger, M., Fisher, P. B., & Grant, S. (1999) · Oncogene · doi:10.1038/sj.onc.1203176 · Cited by 284
Cyclin-dependent protein kinase inhibitors including palbociclib as anticancer drugs
Roskoski, R. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.03.012 · Cited by 237
Arrest of spermatogenesis and defective breast development in mice lacking A-myb
Toscani, A., Mettus, R. V., Coupland, R., Simpkins, H., Litvin, J., Orth, J., Hatton, K. S., & Reddy, E. P. (1997) · Nature · doi:10.1038/386713a0 · Cited by 224
Isolation of human cDNA clones of myb-related genes, A-myb and B-myb
Nomura, N., Takahashi, M., Matsui, M., Ishii, S., Date, T., Sasamoto, S., & Ishizaki, R. (1988) · Nucleic Acids Research · doi:10.1093/nar/16.23.11075 · Cited by 218
Briegel, K., Lim, K. C., Plank, C., Beug, H., Engel, J. D., & Zenke, M. (1993) · Genes & Development · doi:10.1101/gad.7.6.1097 · Cited by 209
A zebrafish bmyb mutation causes genome instability and increased cancer susceptibility
Shepard, J. L., Amatruda, J. F., Stern, H. M., Subramanian, A., Finkelstein, D., Ziai, J., Finley, K. R., Pfaff, K. L., Hersey, C., Zhou, Y., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506583102 · Cited by 160
B-myb Is Required for Inner Cell Mass Formation at an Early Stage of Development
Tanaka, Y., Patestos, N. P., Maekawa, T., & Ishii, S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.40.28067 · Cited by 158
Roberts, A. W., & Huang, D. (2016) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.553 · Cited by 158
Qin, H.-D., Liao, X., Chen, Y., Huang, S.-Y., Xue, W., Li, F.-F., Ge, X.-S., Liu, D.-Q., Cai, Q., Long, J., et al. (2016) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2016.02.021 · Cited by 153
Laßmann, S., Weis, R., Makowiec, F., Roth, J., Danciu, M., Hopt, U. T., & Werner, M. (2006) · Journal of Molecular Medicine · doi:10.1007/s00109-006-0126-5 · Cited by 152
The importance of p53 pathway genetics in inherited and somatic cancer genomes
Stracquadanio, G., Wang, X., Wallace, M. D., Grawenda, A. M., Zhang, P., Hewitt, J., Zerón-Medina-Cuairán, J., Castro-Giner, F., Tomlinson, I. P. M., Goding, C. R., et al. (2016) · Nature reviews. Cancer · doi:10.1038/nrc.2016.15 · Cited by 145
Osterloh, L., von Eyß, B., Schmit, F., Rein, L., Hübner, D., Samans, B., Hauser, S., & Gaubatz, S. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601478 · Cited by 144
Regulation of Neuronal Survival and Death by E2F-Dependent Gene Repression and Derepression
Liu, D. X., & Greene, L. A. (2001) · Neuron · doi:10.1016/s0896-6273(01)00495-0 · Cited by 133
Pilkinton, M. A., Sandoval, R., & Colamonici, O. R. (2007) · Oncogene · doi:10.1038/sj.onc.1210562 · Cited by 132
Poly(ADP-ribose) Polymerase Is a B-MYB Coactivator
Cervellera, M. N., & Sala, A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.14.10692 · Cited by 127
HPV16 E7 oncoprotein deregulates B‐myb expression: correlation with targeting of p107/E2F complexes.
Lam, E. W. ‐., Morris, J. P., Davies, R. C., Crook, T., Watson, R. J., & Vousden, K. H. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06330.x · Cited by 123
Müller, G. A., Quaas, M., Schümann, M., Krause, E., Padi, M., Fischer, M., Litovchick, L., DeCaprio, J. A., & Engeland, K. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr793 · Cited by 121
Park, H. J., Costa, R. H., Lau, L. F., Tyner, A. L., & Raychaudhuri, P. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00387-08 · Cited by 120
Transcriptional activation of the c-myc gene by the c-myb and B-myb gene products.
Nakagoshi, H., Kanei‐Ishii, C., Sawazaki, T., et al. (1992) · PubMed · Cited by 118
Cell cycle molecules define a pathway required for neuron death in development and disease
Greene, L. A., Liu, D. X., Troy, C. M., & Biswas, S. C. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2006.12.003 · Cited by 117
Direct Transactivation of the Anti-apoptotic Gene Apolipoprotein J (Clusterin) by B-MYB
Cervellera, M. N., Raschellà, G., Santilli, G., Tanno, B., Ventura, A., Mancini, C., Sevignani, C., Calabretta, B., & Sala, A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002055200 · Cited by 112
Trauth, K., Mutschler, B., Jenkins, N. A., Gilbert, D. J., Copeland, N. G., & Klempnauer, K.-H. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06945.x · Cited by 110
Constitutive expression of B-myb can bypass p53-induced Waf1/Cip1-mediated G1 arrest.
Lin, D. P., Fiscella, M., O'Connor, P. M., Jackman, J., Chen, M., Luo, L. L., Sala, A., Travali, S., Appella, E., & Mercer, W. E. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.21.10079 · Cited by 110
Biswas, S. C., Shi, Y., Vonsattel, J., Leung, C. L., Troy, C. M., & Greene, L. A. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.3524-06.2007 · Cited by 109
Quaas, M., Müller, G. A., & Engeland, K. (2012) · Cell Cycle · doi:10.4161/cc.22917 · Cited by 107
Activation of human B-MYB by cyclins
Sala, A., Kundu, M., Casella, I., Engelhard, A., Calabretta, B., Grasso, L., Paggi, M. G., Giordano, A., Watson, R. J., Khalili, K., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.2.532 · Cited by 104
Tarasov, K. V., Tarasova, Y. S., Tam, W. L., Riordon, D. R., Elliott, S. T., Kania, G., Li, J., Yamanaka, S., Crider, D. G., Testa, G., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002478 · Cited by 104
B-myb antisense oligonucleotides inhibit proliferation of human hematopoietic cell lines
Arsura, M., Introna, M., Passerini, F., Mantovani, A., & Golay, J. (1992) · Blood · doi:10.1182/blood.v79.10.2708.bloodjournal79102708 · Cited by 104
Yuan, J., Zhang, Y., Sheng, Y., Fu, X., Cheng, H., & Zhou, R. (2015) · Autophagy · doi:10.1080/15548627.2015.1040970 · Cited by 96
Effects of TP53 mutational status on gene expression patterns across 10 human cancer types
Parikh, N., Hilsenbeck, S. G., Creighton, C. J., Dayaram, T., Shuck, R. L., Shinbrot, E., Liu, X., Gibbs, R. A., Wheeler, D. A., & Donehower, L. A. (2013) · The Journal of Pathology · doi:10.1002/path.4321 · Cited by 91
Knight, A. S., Notaridou, M., & Watson, R. J. (2009) · Oncogene · doi:10.1038/onc.2009.22 · Cited by 90
Levenson, V., Davidovich, I., & Roninson, I. B. (2000) · PubMed · Cited by 87
The inhibitory role of Mir-29 in growth of breast cancer cells
Wu, Z., Huang, X., Huang, X., et al. (2013) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-32-98 · Cited by 83
B-MYB Is Required for Recovery from the DNA Damage–Induced G2 Checkpoint in p53 Mutant Cells
Mannefeld, M., Klassen, E., & Gaubatz, S. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4156 · Cited by 82
Hitting the brakes: targeting microtubule motors in cancer
Chandrasekaran, G., Tátrai, P., & Gergely, F. V. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.264 · Cited by 82
Cellular senescence and aging: the role of B‐ MYB
Mowla, S. N., Lam, E. W. ‐., & Jat, P. (2014) · Aging Cell · doi:10.1111/acel.12242 · Cited by 79
Degradation of B-Myb by ubiquitin-mediated proteolysis: involvement of the Cdc34-SCFp45Skp2 pathway
Charrasse, S., Carena, I., Brondani, V., Klempnauer, K.-H., & Ferrari, S. M. (2000) · Oncogene · doi:10.1038/sj.onc.1203618 · Cited by 79
miR-34a Induces the Downregulation of Both E2F1 and B-Myb Oncogenes in Leukemic Cells
Zauli, G., Voltan, R., di Iasio, M. G., Bosco, R., Melloni, E., Sana, M. E., & Secchiero, P. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-3244 · Cited by 75
Cyclin F suppresses B-Myb activity to promote cell cycle checkpoint control
Klein, D. K., Hoffmann, S., Ahlskog, J. K., O’Hanlon, K. A., Quaas, M., Larsen, B. D., Rolland, B., Rösner, H. I., Walter, D., Kousholt, A. N., et al. (2015) · Nature Communications · doi:10.1038/ncomms6800 · Cited by 72
Drosophila myb is required for the G2/M transition and maintenance of diploidyPreprint
Katzen, A. L., Jackson, J., Harmon, B., Fung, S.-M., Ramsay, G. M., & Bishop, J. M. (1998) · Genes & Development · doi:10.1101/gad.12.6.831 · Cited by 71
Raschell�, G., Negroni, A., Sala, A., Pucci, S., Romeo, A., & Calabretta, B. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.15.8540 · Cited by 71
Focal amplifications are associated with high grade and recurrences in stage Ta bladder carcinoma
Nord, H., Segersten, U., Sandgren, J., Wester, K., Busch, C., Menzel, U., Komorowski, J., Dumanski, J. P., Malmström, P., & de Ståhl, T. D. (2009) · International Journal of Cancer · doi:10.1002/ijc.24954 · Cited by 70
Myb controls G2/M progression by inducing cyclin B expression in the Drosophila eye imaginal disc
Okada, M., Akimaru, H., Hou, D., Takahashi, T., & Ishii, S. (2002) · The EMBO Journal · doi:10.1093/emboj/21.4.675 · Cited by 69
Mutation of the Drosophila homologue of the Myb protooncogene causes genomic instability
Manak, J. R., Mitiku, N., & Lipsick, J. S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122231599 · Cited by 68
Liu, D. X., Biswas, S. C., & Greene, L. A. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.1821-04.2004 · Cited by 68
Calvisi, D. F., Simile, M. M., Ladu, S., Frau, M., Evert, M., Tomasi, M. L., Demartis, M. I., Daino, L., Seddaiu, M. A., Brozzetti, S., et al. (2011) · Hepatology · doi:10.1002/hep.24174 · Cited by 65
Novel Molecular Markers for Breast Cancer
Inoue, K., & Fry, E. A. (2016) · Biomarkers in Cancer · doi:10.4137/bic.s38394 · Cited by 65
MYBL2 is an independent prognostic marker that has tumor-promoting functions in colorectal cancer.
Ren, F., Wang, L., Shen, X., Xiao, X., Liu, Z., Wei, P., Wang, Y., Qi, P., Shen, C., Sheng, W., et al. (2015) · Europe PMC (PubMed Central) · Cited by 64
Regulation of B-Myb activity by cyclin D1
Horstmann, S., Ferrari, S. M., & Klempnauer, K.-H. (2000) · Oncogene · doi:10.1038/sj.onc.1203302 · Cited by 62
Myb protein specificity: evidence of a context-specific transcription factor code
Ness, S. A. (2003) · Blood Cells Molecules and Diseases · doi:10.1016/s1079-9796(03)00151-7 · Cited by 62
Fischer, M., Quaas, M., Nickel, A., & Engeland, K. (2015) · Oncotarget · doi:10.18632/oncotarget.6356 · Cited by 61
c-Myb is critical for murine colon development
Zorbas, M., Sicurella, C., Bertoncello, I., et al. (1999) · Oncogene · doi:10.1038/sj.onc.1202971 · Cited by 61
Functional Evolution of the Vertebrate Myb Gene Family
Davidson, C. J., Tirouvanziam, R. M., Herzenberg, L. A., & Lipsick, J. S. (2004) · Genetics · doi:10.1534/genetics.104.034132 · Cited by 58
B-Myb, Cancer, Senescence, and MicroRNAs
Martínez, I., & DiMaio, D. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1044 · Cited by 57
An important role for Myb-MuvB and its target gene KIF23 in a mouse model of lung adenocarcinoma
Iltzsche, F., Simon, K., Stopp, S., Pattschull, G., Francke, S., Wolter, P., Hauser, S., Murphy, D. J., García, P., Rosenwald, A., et al. (2016) · Oncogene · doi:10.1038/onc.2016.181 · Cited by 57
Lorvellec, M., Dumon, S., Maya‐Mendoza, A., Jackson, D. A., Frampton, J., & García, P. (2010) · Stem Cells · doi:10.1002/stem.496 · Cited by 56
Effects of B-Myb on Gene Transcription
Johnson, L. R., Johnson, T. K., Desler, M. M., Luster, T. A., Nowling, T. K., Lewis, R. E., & Rizzino, A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m105112200 · Cited by 56
A transcriptional regulatory element in the coding sequence of the human Bcl‐2 gene
Lang, G., Gombert, W. M., & Gould, H. J. (2004) · Immunology · doi:10.1111/j.1365-2567.2004.02073.x · Cited by 55
Rashid, N. N., Yusof, R., & Watson, R. J. (2011) · Journal of General Virology · doi:10.1099/vir.0.035352-0 · Cited by 55
B- myb is an essential regulator of hematopoietic stem cell and myeloid progenitor cell development
Baker, S. J., Ma’ayan, A., Lieu, Y. K., John, P., Reddy, M. V. R., Chen, E. Y., Duan, Q., Snoeck, H., & Reddy, E. P. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1315464111 · Cited by 54
A B‐Myb complex containing clathrin and filamin is required for mitotic spindle function
Yamauchi, T., Ishidao, T., Nomura, T., Shinagawa, T., Tanaka, Y., Yonemura, S., & Ishii, S. (2008) · The EMBO Journal · doi:10.1038/emboj.2008.118 · Cited by 54
Mutations inDrosophila myblead to centrosome amplification and genomic instability
Fung, S.-M., Ramsay, G. M., & Katzen, A. L. (2002) · Development · doi:10.1242/dev.129.2.347 · Cited by 52
Phosphorylation of B-Myb Regulates Its Transactivation Potential and DNA Binding
Johnson, T. K., Schweppe, R. E., Septer, J., & Lewis, R. E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.51.36741 · Cited by 52
Raschellà, G., Cesi, V., Amendola, R., Negroni, A., Tanno, B., Altavista, P., Tonini, G. P., Bernardi, B. D., & Calabretta, B. (1999) · PubMed · Cited by 52
c-Myb trans-Activates the Human DNA Topoisomerase IIα Gene Promoter
Brandt, T. L., Fraser, D. J., Leal, S., Halandras, P. M., Kroll, A. R., & Kroll, D. J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.10.6278 · Cited by 50
Wolter, P., Hanselmann, S., Pattschull, G., Schruf, E., & Gaubatz, S. (2017) · Oncotarget · doi:10.18632/oncotarget.14466 · Cited by 49
Fuster, Ó., Llop, M., Dolz, S., García, P., Such, E., Ibáñez, M., Luna, I., Gómez‐Seguí, I., López‐Pavía, M., Cervera, J., et al. (2013) · Leukemia Research · doi:10.1016/j.leukres.2013.09.015 · Cited by 47
Li, X.-L., & McDonnell, D. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.11.3663-3673.2002 · Cited by 44
Pang, C. L., Toh, S. Y., He, P., Teissier, S., Khalifa, Y. B., Xue, Y., & Thierry, F. (2013) · Oncogene · doi:10.1038/onc.2013.426 · Cited by 43
Addiction of MYCN Amplified Tumours to B-MYB Underscores a Reciprocal Regulatory Loop
Gualdrini, F., Corvetta, D., Cantilena, S., Chayka, O., Tanno, B., Raschellà, G., & Sala, A. (2010) · Oncotarget · doi:10.18632/oncotarget.138 · Cited by 41
Zhan, M., Riordon, D. R., Yan, B., Tarasova, Y. S., Bruweleit, S., Tarasov, K. V., Li, R. A., Wersto, R. P., & Boheler, K. R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042350 · Cited by 40
García, P., & Frampton, J. (2006) · Journal of Cell Science · doi:10.1242/jcs.02870 · Cited by 37
MYBL2, a link between proliferation and differentiation in maturing colon epithelial cells
Papetti, M., & Augenlicht, L. H. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22399 · Cited by 36
Shi, H., Bevier, M., Johansson, R., Grzybowska, E. A., Chen, B., Eyfjord, J. E., Hamann, U., Manjer, J., Enquist, K., Henriksson, R., et al. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1600-5 · Cited by 35
B-MYB delays cell aging by repressing p16 INK4α transcription
Huang, Y., Wu, J., Li, R., Wang, P., Han, L., Zhang, Z., & Tong, T. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0501-9 · Cited by 34
The cooperation of B-Myb with the coactivator p300 is orchestrated by cyclins A and D1
Schubert, S., Horstmann, S., Bartusel, T., & Klempnauer, K. (2004) · Oncogene · doi:10.1038/sj.onc.1207255 · Cited by 33
Myb binding sites mediate negative regulation of c-myb expression in T- cell lines
Guerra, J., Withers, D. A., & Boxer, L. M. (1995) · Blood · doi:10.1182/blood.v86.5.1873.bloodjournal8651873 · Cited by 32
The RB-related gene Rb2/p130 in neuroblastoma differentiation and in B-myb promoter down-regulation
Raschellà, G., Tanno, B., Bonetto, F., Negroni, A., Claudio, P. P., Baldi, A., Amendola, R., Calabretta, B., Giordano, A., & Paggi, M. G. (1998) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400359 · Cited by 32
Temperature-dependent Modification and Activation of B-MYB
Santilli, G., Schwab, R., Watson, R., Ebert, C., Aronow, B. J., & Sala, A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m411747200 · Cited by 31
Regulation of the cyclin D1 and cyclin A1 promoters by B-Myb is mediated by Sp1 binding sites
Bartusel, T., Schubert, S., & Klempnauer, K. (2005) · Gene · doi:10.1016/j.gene.2005.03.035 · Cited by 30
PARP co-activates B-MYB through enhanced phosphorylation at cyclin/cdk2 sites
Santilli, G., Cervellera, M. N., Johnson, T. K., Lewis, R. E., Iacobelli, S., & Sala, A. (2001) · Oncogene · doi:10.1038/sj.onc.1204943 · Cited by 28
Arsura, M., Luchetti, M. M., Erba, E., Golay, J., Rambaldi, A., & Introna, M. (1994) · Blood · doi:10.1182/blood.v83.7.1778.1778 · Cited by 28
Constitutive expression of c-myb mRNA in the adult rat brain
Shin, D.-H., Lee, H. W., Jeon, G. S., Lee, H. Y., Lee, K. H., & Cho, S. S. (2001) · Brain Research · doi:10.1016/s0006-8993(00)03300-x · Cited by 25
Role of Cdk1 in DNA damage-induced G1 checkpoint abrogation by the human papillomavirus E7 oncogene
Fan, X., & Chen, J. J. (2014) · Cell Cycle · doi:10.4161/15384101.2014.953879 · Cited by 24
Regulation of Ischemic Neuronal Death by E2F4-p130 Protein Complexes
Iyirhiaro, G. O., Zhang, Y., Estey, C., O'Hare, M. J., Safarpour, F., Parsanejad, M., Wang, S., Abdel-Messih, E., Callaghan, S. M., During, M. J., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.574145 · Cited by 23
Disruption of B-myb in DT40 cells reveals novel function for B-Myb in the response to DNA-damage
Ahlbory-Dieker, D. L., Appl, H., Lang, D., & Klempnauer, K. (2005) · Oncogene · doi:10.1038/sj.onc.1208869 · Cited by 23
Functional Analysis of miR-34c as a Putative Tumor Suppressor in High-Grade Serous Ovarian Cancer1
Yu, Z., Kim, J., He, L., Creighton, C. J., Gunaratne, P. H., Hawkins, S. M., & Matzuk, M. M. (2014) · Biology of Reproduction · doi:10.1095/biolreprod.114.121988 · Cited by 22
Mybl2, downregulated during colon epithelial cell maturation, is suppressed by miR-365
Papetti, M., & Augenlicht, L. H. (2011) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00066.2011 · Cited by 21
Joaquin, M., Bessa, M. J., Saville, M. K., & Watson, R. J. (2002) · Oncogene · doi:10.1038/sj.onc.1206001 · Cited by 21
Yang, X., Nakao, Y., Pater, M. M., Tang, S.-C., & Pater, A. (1997) · Journal of Cellular Biochemistry · Cited by 19
Rovani, M. K., Brachmann, C. B., Ramsay, G. M., & Katzen, A. L. (2012) · Developmental Biology · doi:10.1016/j.ydbio.2012.08.022 · Cited by 16
Schwab, R., Caccamo, A. E., Bettuzzi, S., Anderson, J., & Sala, A. (2007) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2007.04.006 · Cited by 12
Maruyama, H., Ishitsuka, Y., Fujisawa, Y., Furuta, J., Sekido, M., & Kawachi, Y. (2014) · Archives of Dermatological Research · doi:10.1007/s00403-014-1450-1 · Cited by 6
Cited by
Cell cycle arrest through indirect transcriptional repression by p53: I have a DREAM
Engeland, K. (2018) · Cell Death & Differentiation · doi:10.1038/cdd.2017.172 · Cited by 656
Sarcoma treatment in the era of molecular medicine
Grünewald, T. G., Alonso, M., Avnet, S., Banito, A., Burdach, S., Cidre‐Aranaz, F., Di Pompo, G., Distel, M., Dorado‐Garcia, H., Garcia‐Castro, J., et al. (2020) · EMBO Molecular Medicine · doi:10.15252/emmm.201911131 · Cited by 319
Self-citationCell cycle transcription control: DREAM/MuvB and RB-E2F complexes.
Fischer, M., & Müller, G. A. (2017) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2017.1360836 · Cited by 255
ATF3 drives senescence by reconstructing accessible chromatin profiles
Zhang, C., Zhang, X., Huang, L., Guan, Y., Huang, X., Tian, X., Zhang, L., & Tao, W. (2021) · Aging Cell · doi:10.1111/acel.13315 · Cited by 84
SOX9 maintains human foetal lung tip progenitor state by enhancing WNT and RTK signalling
Sun, D., Llora Batlle, O., van den Ameele, J., Thomas, J. C., He, P., Lim, K., Tang, W., Xu, C., Meyer, K. B., Teichmann, S. A., et al. (2022) · The EMBO Journal · doi:10.15252/embj.2022111338 · Cited by 38
Metadata
- Authors
- Musa, J., Aynaud, M.-M., Mirabeau, O., Delattre, O., & Grünewald, T. G.
- Venue
- Cell Death & Disease
- Published
- 2017-06-22
- Volume
- 8
- Issue
- 6
- Pages
- e2895-e2895
- ISSN
- 2041-4889 (ISSN-L)
- OpenAlex
- W2718870674
- Cited by
- 322
- References
- 110
- FWCI
- 9.48
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.